Lilly to open Gateway Labs site in Philadelphia
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
Life Science & Biotech
-
Lilly, IU sign clinical trial, research agreement worth up to $40M
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Read More -
Q&A with Cory Lewis, whose emphasis on collaboration has driven INCOG’s rapid growth
Lewis sat down with IBJ to talk about his leadership style and the role of cycling in his life.
Read More -
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard
Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.
Read More -
Gayle Cook, philanthropist and co-founder of Cook companies, dies at 91
Gayle Cook was known for her work in historic preservation—most notably for spearheading the restoration and preservation of the West Baden Springs and French Lick resorts.
Read More
Articles
Heartland BioWorks inks biomanufacturing workforce training agreement
The Bloomington-based Applied Research Institute, which manages Heartland BioWorks, said the agreement will position Indiana as a “central nexus for biomanufacturing training and innovation.”
Lilly CEO calls on state to boost power supply as company seeks to build supercomputer
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Purdue heads clinical trial for new canine cancer treatment
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Heartland BioWorks headquarters planned for 16 Tech
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
Lilly to acquire California-based gene therapy company focused on age-related vision loss
The move continues the Indianapolis-based drugmaker’s investments in age-related diseases.
Pharmaceutical, life science industries drive trade surge between Indiana and Portugal
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
J&J lays out plan to splinter orthopedics business into separate company
The move leaves J&J focused on its pharmaceutical and MedTech segments, which make prescription drugs, contact lenses and technology to treat cardiovascular disease and help with surgeries.
Roche’s FDA-approved vitamin D test clears way for diagnostic growth
The new vitamin D test, to be distributed from the Swiss-based company’s Indianapolis hub, is the first such test using a mass spectrometry-based system to receive regulatory approval in the U.S.
Weight-loss drugs can cut future health costs. The fight is over who pays now.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Potential breakup of Corteva plants kernel of uncertainty
Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.
Elanco reports pet parasite treatment quickly hit $100M blockbuster status
The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis.
Elanco CEO says new products helping to turn the corner on growth
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Lilly signs $1.3B deal with Boston startup for AI-assisted drug development
Superluminal will use its AI-driven platform to discover and optimize small-molecule treatments for G protein-coupled receptors, or GPCRs, which have emerged as a key to conditions such as diabetes and obesity.
UPDATE: Elanco shares jump 16% as company raises full-year guidance
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
IU professor’s work leads to Alzheimer’s blood test
Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a first-of-its-kind blood test to diagnose Alzheimer’s disease.
Lilly acquires cardiovascular genetic medicine company for up to $1.3B
Boston-based Verve Therapeutics is a Nasdaq-traded company focused on genetic medicines for cardiovascular disease.
Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
IU LAB announces accelerator partnerships with Gener8tor, Plug and Play
In addition, IU LAB announced that its accelerator programs will now be called IU Health Incubator at IU LAB, thanks to a $4.5 million, three-year sponsorship deal with IU Health.